Cencora, Inc. COR
Analyst Ratings
- Consensus
- Buy — 11 Buy · 3 Hold · 0 Sell (14 analysts)
- Avg. Price Target
- $375.77 (+7.6% upside)
Key Stats
- Today's Range
- $348.68 – $354.84
- 50-Day Range
- $295.01 – $363.95
- 52-Week Range
- $244.82 – $377.54
- Volume
- 998K shs
- Average Volume
- 1.31 million shs
- Market Cap
- $66.77 billion
- P/E Ratio
- —
- Dividend Yield
- 0.76%
Dividend
- Dividend Yield
- 0.76%
- Annual Dividend
- $2.64
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-11-13
Short Interest
- Short Interest
- 1.46%
- Days to Cover
- 10.26
About Cencora, Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices and global specialty drug logistics (World Courier). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Related Stocks
Compare head-to-head: COR vs HLF·COR vs ZSTK·COR vs COSM·COR vs MEDS
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.